(Yicai) Jan. 7 -- Weimai has secured CNY200 million (USD27.3 million) in its latest funding round that will be used to enable the Chinese provider of one-stop digital healthcare solutions to expand its services and leverage cutting-edge tech in order to meet growing demand for long-term, full-cycle medical care.

The proceeds will be used to step up Weimai’s development of disease management solutions and the use of artificial intelligence and digital tools, said the Hangzhou-based company, which offers continuous health services through its proprietary business model of “Managed Care Organization.”

The Series D funding round attracted a number of new investors, including CNCB Investment, Choice Capital, Yuhang Transformation Industry Investment, Deqing Industry Development Investment, and Nanhu Investment. While several existing shareholders, such as Source Code Capital, Cenova Ventures, and Vision+ Capital, increased their holdings.

Managed Care Organization addresses a wide range of patient needs that include post-diagnosis, post-test, post-surgery, post-hospitalization medication, follow-up consultations, diet, exercise, and rehabilitation.

"MCO is a new concept in China,” said Qiu Jialin, founder and chief executive officer of Weimai. “Since the firm was set up in 2015, we have consistently integrated MCO with China's healthcare reforms, pioneering a uniquely Chinese approach to managed care called C-MCO,” Qiu said.

“Through technological empowerment, we have upgraded healthcare services to provide full-cycle management and closed-loop services across pre-hospital, in-hospital, and post-hospital scenarios,” Qiu added.

Editor: Kim Taylor